← Leaderboards
Matthew Thomas Menard
Brigham And Women'S Hospital
$2,040,511
Attributed
$6,121,533
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2013–18$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,121,533 · 1
By mechanism
U01$6,121,533 · 1
Top collaborators
- Alik Farber5 shared
- Kenneth Rosenfield5 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Michael Salvatore Conte$9,171,065
- Joshua A Beckman$4,886,792
- Daniel I Simon$14,441,938
- Niteesh K Choudhry$10,267,534
- Eva S Schernhammer$12,735,461
Others in their field
Top investigators on “Cost Effectiveness”
- Lawrence Corey · Fred Hutchinson Cancer Center$305,188,797
- David R. Weir · University Of Michigan At Ann Arbor$265,604,440
- Jeffrey P Krischer · University Of South Florida$257,227,881
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Everette D Joseph · Howard University$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
Cost EffectivenessCost EffectiveCostAdverse EventAgingAcademic Medical CentersAmputationAnkleAreaAtherosclerosisBaseBlood VesselsBostonBypassCanadaCardiologyCessation Of LifeClinical CareClinical DataClinical Trials DesignCohortCommunitiesComparative EffectivenessCost Effectiveness Analysis
Grant awards (5)
BEST-CLI Trial-CCC-Lead$1,838,598
U01 · FY2018 · HL · contact PI
BEST-CLI Trial-CCC-Lead$1,233,529
U01 · FY2017 · HL · contact PI
BEST-CLI Trial-CCC-Lead$634,074
U01 · FY2016 · HL · contact PI
BEST-CLI Trial-CCC-Lead$1,214,396
U01 · FY2015 · HL · contact PI
BEST-CLI Trial-CCC-Lead$1,200,936
U01 · FY2013 · HL · contact PI